Laborie

Laborie

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Laborie is a well-established, revenue-generating private medical device company with a 60-year history focused on niche diagnostic and therapeutic markets. It maintains a diversified portfolio of commercialized products and systems for urodynamics, anorectal manometry, GI diagnostics, and obstetric/neonatal care, supported by a strong global educational platform for clinicians. The company leverages strategic acquisitions and internal innovation to expand its offerings, recently entering the therapeutic urology space with devices like the Optilume BPH Catheter System. Its business model is built on direct sales of medical equipment, disposables, and services, targeting hospitals and specialty clinics worldwide.

UrologyUrogynecologyGastroenterologyObstetricsGynecologyNeonatal

Technology Platform

Integrated ecosystem of functional diagnostic measurement systems (urodynamics, GI manometry) and therapeutic devices, supported by proprietary hardware, software, and single-use disposables. Complemented by a robust global clinical education platform.

Funding History

1
UndisclosedUndisclosed

Opportunities

Expansion into therapeutic urology (e.g., BPH with Optilume) opens large, growing markets beyond diagnostics.
Global growth, particularly in emerging markets like China, presents a significant opportunity.
Leveraging its strong clinical education platform to drive adoption of new technologies and deepen customer loyalty.

Risk Factors

Intense competition from both specialized rivals and large medtech conglomerates across all product segments.
Regulatory and reimbursement challenges across multiple global markets can impact market access and profitability.
Successful integration of acquired technologies and continuous innovation are required to avoid obsolescence.

Competitive Landscape

Laborie competes in specialized niches against companies like Medtronic and Diversatek in GI diagnostics, and within urology against players such as Boston Scientific, Olympus, and numerous BPH therapy specialists. Its differentiation stems from deep clinical specialization, a comprehensive product portfolio across the care pathway, and a unique, extensive focus on clinician education and training.